Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine intraperitoneal perioperative use to shorten time to adjuvant chemotherapy in advanced ovarian cancer
2019-003299-38Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ovarian cancer and postoperative pain comparing Intraperitoneal ropivacaine with Placebo / control (2 arms). Primary endpoint: Time from surgery to start of adjuvant chemotherapy. Started Oct 2019; status: active.
02
Drugs
ropivacaine
03
Conditions
ovarian cancerpostoperative pain
Beyond the preview
Go deeper on 2019-003299-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003299-38.